德克萨米他松棕酸盐:对于严重的突然听力损失来说,这是一个有前途的内耳膜治疗选择
1Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
American journal of otolaryngology
|December 17, 2025
概括
德克萨米他松棕酸 (DXP) 显示出对突然感觉神经听力损失 (SSNHL) 治疗的希望. 早期的DXP注射改善了三分之二的患者的听力,没有任何不良影响.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
- 再生医学是一种再生医学.
背景情况:
- 突然感觉神经听力损失 (SSNHL) 需要有效的治疗方法.
- 脂友性皮质类固醇,如德甲棕酸盐 (DXP) 提供持续释放的入治疗.
- 在SSNHL治疗中,DXP可能会改善传统的德克萨米他.
研究的目的:
- 评估SSNHL患者内内DXP注射的安全性和临床结果.
- 评估DXP在改善听力值和语音歧视方面的有效性.
主要方法:
- 三名患有深度SSNHL的患者接受了全身类固醇,高压氧气和六次静脉内膜DXP.
- 对疼痛,炎症或 tympanic 膜问题等不良影响进行了安全监测.
- 听力门和言语歧视在3个月内进行了评估.
主要成果:
- 三分之二的患者在3个月内有显著的听力改善.
- 一个迟到出现的患者没有显示听力恢复.
- 没有报告任何不良事件,这表明DXP的安全性概况有利.
结论:
- 内DXP似乎是SSNHL的安全治疗选择.
- 早期服用DXP可能会增强耳药物输送和治疗保留,从而导致更好的结果.
- DXP是SSNHL管理的潜在有效替代方案.
更多相关视频
06:55A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
Published on: February 27, 2018
9.1K
03:49Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
1.2K
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
